Product Information

ERYTHROMYCIN 200 MG/5 ML SUSP is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.9433 per ML under NDC 60219150301. Its NADAC has been published 134 times since May 1, 2024.

FDA first approved this application on Nov 1, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ERYTHROMYCIN 200 MG/5 ML SUSP

Erythromycin
$0.9433per ML

Strength

200 mg/5mL

NDC

60219150301

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ERYTHROMYCIN ETHYLSUCCINATE

Approval Type

Generic (ANDA)

FDA Application

ANDA211204

FDA Approved

11/1/2019

TE Code

AB

On Market Since

12/2/2023

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price Statistics

The NADAC for ERYTHROMYCIN 200 MG/5 ML SUSP has been published 134 times since May 1, 2024, and over the history we have for it it has risen 28.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9433 per ML
All-time high$1.4594 (Nov 13, 2024)
All-time low$0.7325 (May 1, 2024)
52-week high$1.0408
52-week low$0.7608
Median price$0.9787
Average price$1.0137
Largest weekly change-33.9% (Nov 20, 2024)
Weeks tracked134
Tracking sinceMay 1, 2024

Price History

1W

-3.6%

1M

+3.4%

3M

+3.2%

6M

+13.1%

1Y

+2.6%

3Y

N/A

5Y

N/A

All

+28.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ERYTHROMYCIN 200 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 200 MG/5 ML SUSP, manufactured by Amneal Pharmaceuticals NY LLC, is $0.9433 per ML (NDC 60219150301), effective Nov 18, 2026.

How has the price of ERYTHROMYCIN 200 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for ERYTHROMYCIN 200 MG/5 ML SUSP has risen 28.8%. It has been tracked across 134 weekly CMS publications since May 1, 2024.

What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 200 MG/5 ML SUSP?

Since May 1, 2024, the NADAC for ERYTHROMYCIN 200 MG/5 ML SUSP has ranged from a low of $0.7325 (May 1, 2024) to a high of $1.4594 (Nov 13, 2024), with a median of $0.9787 per ML.

Are there cheaper alternatives to ERYTHROMYCIN 200 MG/5 ML SUSP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ERYTHROMYCIN 200 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.

Who manufactures ERYTHROMYCIN 200 MG/5 ML SUSP?

ERYTHROMYCIN 200 MG/5 ML SUSP (NDC 60219150301) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.